HU9603065D0 - New opioid peptide analogs with mixed mu agonist/delta antagonist properties - Google Patents
New opioid peptide analogs with mixed mu agonist/delta antagonist propertiesInfo
- Publication number
- HU9603065D0 HU9603065D0 HU9603065A HU9603065A HU9603065D0 HU 9603065 D0 HU9603065 D0 HU 9603065D0 HU 9603065 A HU9603065 A HU 9603065A HU 9603065 A HU9603065 A HU 9603065A HU 9603065 D0 HU9603065 D0 HU 9603065D0
- Authority
- HU
- Hungary
- Prior art keywords
- agonist
- mixed
- peptide analogs
- antagonist properties
- opioid peptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
- C07K5/126—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9401596A SE9401596D0 (sv) | 1994-05-06 | 1994-05-06 | New compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HU9603065D0 true HU9603065D0 (en) | 1997-01-28 |
Family
ID=20393941
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9603065A HU9603065D0 (en) | 1994-05-06 | 1995-04-27 | New opioid peptide analogs with mixed mu agonist/delta antagonist properties |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5786447A (hu) |
| EP (1) | EP0763062A1 (hu) |
| JP (1) | JPH10500404A (hu) |
| CN (1) | CN1147819A (hu) |
| AU (1) | AU688040B2 (hu) |
| BR (1) | BR9507620A (hu) |
| CA (1) | CA2188670A1 (hu) |
| FI (1) | FI964443A (hu) |
| HU (1) | HU9603065D0 (hu) |
| IL (1) | IL113441A0 (hu) |
| IS (1) | IS4377A (hu) |
| MX (1) | MX9605352A (hu) |
| NO (1) | NO964670D0 (hu) |
| NZ (1) | NZ285476A (hu) |
| PL (1) | PL317049A1 (hu) |
| SE (1) | SE9401596D0 (hu) |
| SK (1) | SK136596A3 (hu) |
| WO (1) | WO1995030694A1 (hu) |
| ZA (1) | ZA953315B (hu) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6703381B1 (en) | 1998-08-14 | 2004-03-09 | Nobex Corporation | Methods for delivery therapeutic compounds across the blood-brain barrier |
| AUPP616498A0 (en) * | 1998-09-25 | 1998-10-15 | University Of Queensland, The | Synthesis of cyclic peptides |
| US10010617B2 (en) * | 2011-05-18 | 2018-07-03 | Eumederis Pharmaceuticals, Inc. | Peptide pharmaceuticals |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0680079B2 (ja) * | 1984-11-09 | 1994-10-12 | エーザイ株式会社 | ポリペプチド |
-
1994
- 1994-05-06 SE SE9401596A patent/SE9401596D0/xx unknown
-
1995
- 1995-04-20 IL IL11344195A patent/IL113441A0/xx unknown
- 1995-04-24 ZA ZA953315A patent/ZA953315B/xx unknown
- 1995-04-27 MX MX9605352A patent/MX9605352A/es unknown
- 1995-04-27 SK SK1365-96A patent/SK136596A3/sk unknown
- 1995-04-27 EP EP95918807A patent/EP0763062A1/en not_active Withdrawn
- 1995-04-27 WO PCT/SE1995/000462 patent/WO1995030694A1/en not_active Application Discontinuation
- 1995-04-27 CA CA002188670A patent/CA2188670A1/en not_active Abandoned
- 1995-04-27 BR BR9507620A patent/BR9507620A/pt not_active Application Discontinuation
- 1995-04-27 PL PL95317049A patent/PL317049A1/xx unknown
- 1995-04-27 NZ NZ285476A patent/NZ285476A/en unknown
- 1995-04-27 AU AU24583/95A patent/AU688040B2/en not_active Ceased
- 1995-04-27 HU HU9603065A patent/HU9603065D0/hu unknown
- 1995-04-27 CN CN95192952A patent/CN1147819A/zh active Pending
- 1995-04-27 JP JP7528880A patent/JPH10500404A/ja active Pending
- 1995-04-27 US US08/448,472 patent/US5786447A/en not_active Expired - Fee Related
-
1996
- 1996-10-21 IS IS4377A patent/IS4377A/is unknown
- 1996-11-05 FI FI964443A patent/FI964443A/fi unknown
- 1996-11-05 NO NO964670A patent/NO964670D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US5786447A (en) | 1998-07-28 |
| IS4377A (is) | 1996-10-21 |
| WO1995030694A1 (en) | 1995-11-16 |
| EP0763062A1 (en) | 1997-03-19 |
| IL113441A0 (en) | 1995-07-31 |
| BR9507620A (pt) | 1997-08-19 |
| NZ285476A (en) | 1998-04-27 |
| CA2188670A1 (en) | 1995-11-16 |
| FI964443A0 (fi) | 1996-11-05 |
| CN1147819A (zh) | 1997-04-16 |
| SK136596A3 (en) | 1997-06-04 |
| FI964443A (fi) | 1996-11-05 |
| NO964670L (no) | 1996-11-05 |
| AU2458395A (en) | 1995-11-29 |
| PL317049A1 (en) | 1997-03-03 |
| SE9401596D0 (sv) | 1994-05-06 |
| MX9605352A (es) | 1997-12-31 |
| JPH10500404A (ja) | 1998-01-13 |
| ZA953315B (en) | 1995-11-06 |
| AU688040B2 (en) | 1998-03-05 |
| NO964670D0 (no) | 1996-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0102658A3 (en) | Pharmaceutical composition containing opioid agonist and antagonist combination | |
| PT1255547E (pt) | Composições de libertação controlada contendo agonistas e antagonistas opióides | |
| HUP9600056A3 (en) | Estrogen agonists/antagonists | |
| EP0819005A4 (en) | 2-ACYLAMINOPROPANAMIDES AS TACHYKININ RECEPTOR ANTAGONISTS | |
| IL140770A0 (en) | N-substituted naphthalene carboxamides as neurokinin-receptor antagonists | |
| ZA956561B (en) | New peptide derivatives with delta opioid receptor antagonist or mixed mu agonist/delta antagonist effects | |
| PL341114A1 (en) | Antagonists of thrombosin receptors | |
| PL310386A1 (en) | Antagonists of factor i receptors | |
| NZ324712A (en) | 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists | |
| IL142045A0 (en) | Naphthalenecarboxamides as tachykinin receptor antagonists | |
| GB2354289B (en) | Fuel-air mixture apparatus | |
| HUP0002929A3 (en) | 2-acylaminopropanamines as tachykinin receptor antagonists and pharmaceutical compositions containing the same | |
| HU9603065D0 (en) | New opioid peptide analogs with mixed mu agonist/delta antagonist properties | |
| AU8056094A (en) | Opioid receptor: compositions and methods | |
| PL331426A1 (en) | Pharmaceutic composition containing the 5ht2c antagonist and the d2 antagonist | |
| HUP9903653A3 (en) | Substituted arylalkylamines as neurokinin antagonists | |
| AU695175C (en) | New peptide derivatives with delta opioid receptor antagonist or mixed mu agonist/delta antagonist effects | |
| HUP0003548A3 (en) | 2-acylaminopropanamines as tachykinin receptor antagonists and pharmaceutical compositions containing the same | |
| FI965116A0 (fi) | Uusia opioidipeptidiantagonisteja | |
| HUP9902674A2 (en) | Use of estrogen agonists/antagonists as a medicament | |
| PL330961A1 (en) | Virginiamycin containing mixture | |
| AU5239898A (en) | Phenyl spiroethercycloalkyl tachykinin receptor antagonists | |
| HU0800727D0 (hu) | Opioid agonista és antagonista hatóanyagot tartalmazó gyógyszerkészítmény | |
| ZA954311B (en) | New oploid peptide antagonists | |
| ZA9510618B (en) | Tachykinin antagonists |